We read with interest the paper by Layer et al. regarding the identification of staphylococci with automated systems including VITEK-2 (bioMérieux, Marcy l'Etoile, France) (6). Of 86 strains analyzed in their study, 4 were Staphylococcus hominis and all were correctly identified by the colorimetric ID-GP VITEK-2 cards. Identical results have been reported in recent studies evaluating 13 and 14 S. hominis isolates (3, 7).
Authors' Reply
We read the letter by Gilad and Schwartz regarding our publication (4), and we are glad to comment on their observations about the species Staphylococcus hominis subsp. hominis and S. hominis subsp. novobiosepticus. In our strain collection for the publication (4), we analyzed four S. hominis strains. Identification by VITEK-2 revealed S. hominis without identification to the subspecies level. But the confidence level for the species identification was 99%. The two S. hominis subspecies-subspecies hominis and subspecies novobiosepticus-can be differentiated according to novobiocin susceptibility. Therefore, we identified to the subspecies level the respective S. hominis strains and six additional clinical isolates of S. hominis (n ϭ 10) by using novobiocin susceptibility testing and one reference strain of S. hominis subsp. hominis (CCM2732). Additionally, as a control for novobiocin susceptibility, we tested 12 clinical isolates of S. epidermidis as novobiocin sensitive (2) and one reference strain of S. saprophyticus subsp. saprophyticus as novobiocin resistant (2) . Isolates were inoculated onto Mueller-Hinton agar (Oxoid Ltd., Basingstoke, Hampshire, England) according to Clinical Laboratory Standards Institute guidelines (1) and tested with a 5-g novobiocin disk (Oxoid, Basingstoke, Hampshire, England). A zoneof-inhibition diameter of Ͻ15 mm was considered to indicate resistance (3).
We did not observe novobiocin resistance in all S. hominis strains tested, including the reference control strain of S. hominis subsp. hominis. The clinical control strains of S. epidermidis were all novobiocin sensitive, and the reference control strain of S. saprophyticus subsp. saprophyticus was novobiocin resistant by the disk diffusion test (Table 1) .
Novobiocin resistance testing is one of 43 reactions carried out by the GP card of the VITEK-2 system. All isolates were processed by using VITEK-2 according to the manufacturer's instructions. In our hands, novobiocin susceptibility results from the VITEK-2 ID-GP card correlated with disk diffusion results by manual testing.
So far, in our clinical setting we have not observed any occurrence of S. hominis subsp. novobiosepticus, but in future studies we will look out for the issue of the subspecies differentiation for S. hominis.
